Search Results
Apr 21, 2026, 10:01 ET Paradigm Health Launches SPIRE to Accelerate Late-Phase Clinical Evidence Generation
highlight SPIRE's operational benefits in a poster titled "A pragmatic, hybrid observational study evaluating the effectiveness of trastuzumab deruxtecan (T-DXd) in patients with human epidermal growth factor receptor 2 (HER2) immunohistochemistry (IHC) 3+ solid tumors: DESTINY-PanTumor04."SPIRE builds
More news about: Paradigm Health, Inc.
Apr 21, 2026, 10:00 ET Renuity Appoints Stuart Dunleavy as Chief Marketing Officer to Accelerate Growth, Brand Momentum, and Customer Innovation
exceptional talent, and build the Renuity brand into a household name."Dunleavy most recently served as Vice President of Consumer Marketing at AT&T where he led large, cross-functional teams responsible for acquisition, growth, and retention across AT&T's more than 100 consumer connections
More news about: Renuity
Apr 21, 2026, 09:38 ET NKTR INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Nektar Therapeutics (NKTR) Investors of Securities Class Action Deadline on May 5, 2026
induction treatment period of the Phase 2b REZOLVE-AA trial of investigational rezpegaldesleukin, a first-in-class IL-2 pathway agonist and regulatory T-cell (Treg) proliferator." The press release disclosed that the trial failed to reach statistical significance, which Nektar attributed to the inclusion
More news about: Faruqi & Faruqi, LLP
Apr 21, 2026, 09:38 ET Intune Physical Therapy Expands into Alabama with Acquisition of Nesin Physical Therapy
PalumboE: [email protected]T: (847) 905-9025
More news about: Intune Physical Therapy
Apr 21, 2026, 09:30 ET Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic
procedure is a specialized blood draw that is necessary to collect a patient's immune cells for immunotherapies such as DCVax as well as CAR-Ts and other T cell therapies, and for certain other types of therapies. The procedure takes about 4 hours and involves filtering the patient's blood through special
More news about: Northwest Biotherapeutics, Inc.
Apr 21, 2026, 09:30 ET Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic
procedure is a specialized blood draw that is necessary to collect a patient's immune cells for immunotherapies such as DCVax as well as CAR-Ts and other T cell therapies, and for certain other types of therapies. The procedure takes about 4 hours and involves filtering the patient's blood through special
More news about: Northwest Biotherapeutics, Inc.
Apr 21, 2026, 09:02 ET Neurophos Enters Hypergrowth Phase After $110M Series A
over a decade of cutting-edge photonic IC development experience to Neurophos from Lumentum, Infinera, and Intel, where he led PIC development for 1.6T pluggable optics as the Technical Lead for Silicon Photonics and PIC development.Tsachy Holovinger - Director of Quality, Reliability, and Failure
More news about: Neurophos
Apr 21, 2026, 09:00 ET Keurig Dr Pepper and Nestlé USA Extend Strategic Partnership
nestleusa.com. Contacts:Investors:Keurig Dr Pepper Investor RelationsT: 888-340-5287 / [email protected] Media:Keurig Dr PepperKatie GilroyT: 781-418-3345 /
More news about: Keurig Dr Pepper
Apr 21, 2026, 09:00 ET The City Never Sleeps on 420: Inside Travel Agency's New York-Driven 420 Campaign
Only NY. At the center of the collection is a special-edition t-shirt featuring an elevated take on the original "High Flyer" pigeon character, a High Flyer plushie keychain, magnets, archival t-shirts, Only NY's iconic cast-iron pigeons and a one-of-a-kind New York sewer cap ashtray.
More news about: The Travel Agency
Apr 21, 2026, 09:00 ET Digital Strategist Nav Thethi Signals $383B "AI Yield Crisis," Launches MATURITY Code to Address Enterprise Value Erosion
of current state versus institutional standards.[A] Align: Mapping AI capabilities directly to core business objectives.[T] Translate: Converting high-level potential into operational use cases.[U] Upskill: Transitioning the workforce from "Prompters" to
More news about: TNT4
Apr 21, 2026, 09:00 ET Purple Knight Now Delivers Comprehensive Identity Security Assessments for Microsoft GCC High Environments
low-friction tools to validate whether that perimeter is truly resilient," said Dr. Ed Amoroso, CEO of TAG Cyber and former Chief Security Officer of AT&T. "Extending Purple Knight into GCC High gives federal defenders a fast, community-driven way to benchmark their hybrid identity posture against the
More news about: Semperis
Apr 21, 2026, 09:00 ET Mindtickle launches ElevateOS™ -- the first agentic operating system for revenue enablement
reputational test. Reps must prove value in every conversation, or buyers disengage fast. "With these changes in the landscape, t he revenue enablement industry is at an inflection point. The old model of enablement does not work. Training harder, creating more content, and more
More news about: Mindtickle
Apr 21, 2026, 09:00 ET As SpaceX Moves Toward a Record-Setting IPO, The Non-SpaceX Space Infrastructure Stack Is Being Repriced -- And One MACH 2+ Air-Launch Operator Is Quietly Stacking Partnerships
securities carries a high degree of risk; you may likely lose some or all of the investment.Sources:[1] Techi, "SpaceX IPO 2026: $1.75T Valuation, SEC Filing & How to Invest 2026," April 2026, citing Bloomberg, TechCrunch, The Wall Street Journal, and CNBC reporting on SpaceX's confidential
More news about: Equity Insider
Apr 21, 2026, 08:30 ET HKeybio Launches World's First NHP Hidradenitis Suppurativa Model with High Clinical Consistency to Tackle Global Drug R&D Bottleneck
cytokine storms observed in clinical cases.Immune Microenvironment: Flow cytometry reveals a sophisticated infiltration of activated T cells, M2 macrophages, neutrophils, and mast cells, consistent with findings published in Journal of Investigative Dermatology (2023) and British Journal
More news about: HKeyBio
Apr 21, 2026, 08:00 ET Deep Blue Medical Closes Oversubscribed $5.6M Series A and Elevates Veteran Leader to COO
The proceeds will fuel the commercial launch of Deep Blue's biosynthetic absorbable T-Line® Mesh, support expansion into aesthetic and breast applications, and deepen already extensive relationships with key opinion leaders and hospital
More news about: Deep Blue Medical Advances, Inc.
Apr 21, 2026, 08:00 ET Minaris Delivers 100% Manufacturing and Release Success for Chimeric Therapeutics' CDH17 Autologous CAR‑T Program
first in class autologous CAR T cell therapies and best in class allogeneic NK cell therapies. Chimeric assets are being developed across multiple different disease areas in oncology with 4 clinical stage programs.CHM CDH17 is a first-in-class, 3rd generation CDH17 CAR T invented at the world-renowned
More news about: Minaris Advanced Therapies
Apr 21, 2026, 08:00 ET Minaris Delivers 100% Manufacturing and Release Success for Chimeric Therapeutics' CDH17 Autologous CAR‑T Program
first in class autologous CAR T cell therapies and best in class allogeneic NK cell therapies. Chimeric assets are being developed across multiple different disease areas in oncology with 4 clinical stage programs.CHM CDH17 is a first-in-class, 3rd generation CDH17 CAR T invented at the world-renowned
More news about: Minaris Advanced Therapies
Apr 21, 2026, 08:00 ET Celltrion to present seven abstracts in inflammatory bowel disease (IBD) at 2026 Digestive Disease Week® (DDW)
first dose of therapy. Most of the patients were receiving concomitant immunosuppressants.Post-marketing cases of hepatosplenic T-cell lymphoma, a rare type of T-cell lymphoma, have been reported in patients treated with TNF blockers, including infliximab products. These cases have had a very aggressive
More news about: Celltrion
Apr 21, 2026, 07:00 ET Castle Biosciences to Present New Data Demonstrating DecisionDx®-Melanoma's Ability to Identify Patients with Greater Risk of Recurrence and Poor Outcomes Within Early-Stage Melanoma at EADO and ACMS
(SEER) registry data showing that DecisionDx‑Melanoma can provide prognostic insight beyond AJCC staging in patients with thin T1a and T1b CM. The test identified molecularly high‑risk T1 patients with significantly lower 5‑year melanoma‑specific survival and, when combined with staging, identified more patients
More news about: Castle Biosciences, Inc.
Apr 21, 2026, 07:00 ET GRUPO AVAL ANNOUNCES THE FILING OF ITS FORM 20-F FOR THE YEAR ENDED DECEMBER 31, 2025
[email protected] Bogotá, ColombiaT: +57 - 6017433222
More news about: Grupo Aval
Apr 21, 2026, 07:00 ET AppZen launches AP Inbox Service Center, bringing AI Agents to the most manual process in accounts payable
geography."More than 500 global enterprises, including over 65 of the Fortune 500, rely on AppZen to automate transaction processing and reduce costs across T&E, accounts payable, and corporate card programs, delivering over $2 billion in collective savings and enabling finance teams to reallocate up to two-thirds
More news about: AppZen
Apr 21, 2026, 07:00 ET Greenvit Debuts ARONVIT® for Gut Health and Microbiota at Vitafoods Europe
www.nutripr.com References1. Ren, T., et al. (2022). "Modulation of the gut microbiota and lipidomic profiles by black chokeberry (Aronia melanocarpa L.) polyphenols." Frontiers
More news about: Greenvit
Apr 21, 2026, 06:55 ET RTX Reports Q1 2026 Results
million were up 10 percent versus the prior year. This increase was driven by higher volume on land and air defense systems, including Patriot and GEM-T, as well as higher volume on naval munitions programs. Raytheon reported operating profit of $841 million was up 24 percent versus the prior
More news about: RTX
Apr 21, 2026, 05:57 ET From Molecular Design to Scalable Execution: The Combined Impact of AI and Flow Chemistry
delivery.Full Webinar Replay: https://www.youtube.com/watch?v=OUjVDHKjqIM&t=2915s
More news about: Viva Biotech
Apr 21, 2026, 03:43 ET RoboSense Unveiled EOCENE SPAD-SoC Architecture and Chipsets Phoenix and Peacock: Ushering the LiDAR Industry into the Image-grade Era of High-Definition 3D Perception
https://www.dropbox.com/scl/fo/zafeavobmdke8cp0mgmtt/AKduk648136gxk3w9moF87o?rlkey=5n0n2843o5hpvqgm0fxmi2q9t&st=nagfu804&dl=0About RoboSenseRoboSense (02498 HKEX) is an AI-driven robotics
More news about: RoboSense Technology Co., Ltd.